Basecamp Wealth Advisors’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.44K Buy
285
+21
+8% +$471 ﹤0.01% 1114
2026
Q1
$5.96K Sell
264
-21
-7% -$482 ﹤0.01% 1142
2025
Q4
$6.79K Buy
+285
New +$7.09K ﹤0.01% 1082

Other funds holding FMS

Basecamp Wealth Advisors's FMS Position: Q2 2026 in Review

Basecamp Wealth Advisors increased its Fresenius Medical Care (FMS) stake by 8% in Q2 2026, buying an estimated $471 and bringing the position to 285 shares worth $6.44K. The position accounts for ﹤0.01% of the portfolio, ranked #1114.

Basecamp Wealth Advisors first reported a position in FMS in Q4 2025 and has held it in 3 quarters since. The position peaked at $6.79K in Q4 2025. 233 funds tracked by Wall St. Rank hold FMS as of Q2 2026.

  • Basecamp Wealth Advisors held 285 shares of Fresenius Medical Care worth $6.44K as of Q2 2026.
  • Basecamp Wealth Advisors bought 21 Fresenius Medical Care shares in Q2 2026, an estimated $471.
  • Fresenius Medical Care made up ﹤0.01% of Basecamp Wealth Advisors's portfolio in Q2 2026, its #1114 holding.
  • Basecamp Wealth Advisors first reported a position in Fresenius Medical Care in Q4 2025 and has held it in 3 quarters since.
  • Basecamp Wealth Advisors's Fresenius Medical Care position peaked at $6.79K in Q4 2025.
  • 233 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q2 2026.

Based on Basecamp Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.